Target Name: GRPR
NCBI ID: G2925
Review Report on GRPR Target / Biomarker Content of Review Report on GRPR Target / Biomarker
GRPR
Other Name(s): GRP-R | BRS2 | Gastrin releasing peptide receptor | Bombesin BB2 (gastrin-releasing peptide) receptor | GRP-preferring bombesin receptor | BB2 | gastrin releasing peptide receptor | BB2R | Gastrin-releasing peptide receptor | GRPR_HUMAN | bombesin receptor 2

Discovering The Potential Drug Targets GPRs: Unlocking The Secrets of Transmembrane Proteins

G protein-coupled receptors (GRPs) are a family of transmembrane proteins that play a crucial role in cellular signaling. They are involved in various physiological processes, including sensory perception, neurotransmission, and hormone signaling. GPRs are potential drug targets and have been identified as potential biomarkers for various diseases. In this article, we will discuss GRPRs in detail, including their structure, function, and potential as drug targets.

Structure and Function

GRPs are a subfamily of G protein-coupled receptors that consists of seven different subfamilies, including GPRs, GPR-伪, GPR-尾, GPR-纬, GPR-未, GPR-蔚, and GPR-味. These subfamilies differ in their extracellular loop (ECL) and transmembrane region (TMR) lengths and the presence or absence of various intracellular signaling pathways, including FAK, PLC, and TRK.

GRPs are involved in various physiological processes, including sensory perception, neurotransmission, and hormone signaling. They are involved in the transmission of signals from the sensory system to the brain and play a crucial role in the regulation of neurotransmitter release. They are also involved in the regulation of ion channels, including the sodium and calcium channels that are responsible for neurotransmission. In addition, GRPs are involved in the regulation of inflammation and are thought to play a role in the development of various diseases, including cancer and neurodegenerative diseases.

GRPs are also potential drug targets due to their unique structure and function. They are involved in a wide range of diseases, including cancer, neurodegenerative diseases, and behavioral disorders. For example, GPRs are involved in the regulation of pain perception and have been targeted by various painkillers, including opioids and nonsteroidal anti-inflammatory drugs (NSAIDs). In addition, GPRs are involved in the regulation of anxiety and have been targeted by various antidepressants.

GPRs are also involved in the regulation of hormone signaling, including the regulation of testosterone and estrogen levels. They are thought to play a role in the development of various diseases, including prostate cancer and breast cancer. In addition, GPRs are involved in the regulation of insulin sensitivity and have been linked to the development of type 2 diabetes.

Potential Therapeutic Applications

GRPs are a promising drug target due to their unique structure and function. They are involved in various physiological processes and are thought to play a role in the development of various diseases. As a result, they are a potential therapeutic target for a wide range of diseases, including cancer, neurodegenerative diseases, and behavioral disorders.

One of the main advantages of GRPs is their diverse range of functions. For example, GPRs are involved in the regulation of pain perception, neurotransmission, and hormone signaling. They are also involved in the regulation of ion channels, including the sodium and calcium channels that are responsible for neurotransmission. In addition, GRPs are involved in the regulation of inflammation and have been thought to play a role in the development of various diseases, including cancer and neurodegenerative diseases.

Another advantage of GRPs is their unique structure. They have a long extracellular loop (ECL) and a short transmembrane region (TMR), which allows them to interact with a wide range of molecules. This makes them a versatile target for drug development. For example, GPRs have been targeted by various painkillers, including opioids and nonsteroidal anti-inflammatory drugs (NSAIDs). In addition, GPRs have also been targeted by various antidepressants and have been shown to have anxiolytic and anti-inflammatory effects.

GRPs are also involved in the regulation of hormone signaling, including the regulation of testosterone and estrogen levels. They are

Protein Name: Gastrin Releasing Peptide Receptor

Functions: Receptor for gastrin-releasing peptide (GRP) (PubMed:1655761). Signals via association with G proteins that activate a phosphatidylinositol-calcium second messenger system, resulting in Akt phosphorylation. Contributes to the regulation of food intake. Contributes to the perception of prurient stimuli and transmission of itch signals in the spinal cord that promote scratching behavior, but does not play a role in the perception of pain. Contributes primarily to nonhistaminergic itch sensation. In one study, shown to act in the amygdala as part of an inhibitory network which inhibits memory specifically related to learned fear (By similarity). In another study, shown to contribute to disinhibition of glutamatergic cells in the auditory cortex via signaling on vasoactive intestinal peptide-expressing cells which leads to enhanced auditory fear memories (By similarity). Contributes to the induction of sighing through signaling in the pre-Botzinger complex, a cluster of several thousand neurons in the ventrolateral medulla responsible for inspiration during respiratory activity (By similarity)

The "GRPR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GRPR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GRSF1 | GRTP1 | GRTP1-AS1 | GRWD1 | GRXCR1 | GRXCR2 | GS1-24F4.2 | GS1-600G8.3 | GSAP | GSC | GSC2 | GSDMA | GSDMB | GSDMC | GSDMD | GSDME | GSE1 | GSEC | GSG1 | GSG1L | GSG1L2 | GSK3A | GSK3B | GSKIP | GSN | GSPT1 | GSPT2 | GSR | GSS | GSTA1 | GSTA12P | GSTA2 | GSTA3 | GSTA4 | GSTA5 | GSTA7P | GSTCD | GSTK1 | GSTM1 | GSTM2 | GSTM2P1 | GSTM3 | GSTM4 | GSTM5 | GSTM5P1 | GSTO1 | GSTO2 | GSTP1 | GSTT1 | GSTT2 | GSTT2B | GSTT4 | GSTTP2 | GSTZ1 | GSX1 | GSX2 | GTDC1 | GTF2A1 | GTF2A1L | GTF2A2 | GTF2B | GTF2E1 | GTF2E2 | GTF2F1 | GTF2F2 | GTF2H1 | GTF2H2 | GTF2H2B | GTF2H2C | GTF2H2C_2 | GTF2H3 | GTF2H4 | GTF2H5 | GTF2I | GTF2I-AS1 | GTF2IP1 | GTF2IP12 | GTF2IP20 | GTF2IP4 | GTF2IP7 | GTF2IRD1 | GTF2IRD1P1 | GTF2IRD2 | GTF2IRD2B | GTF2IRD2P1 | GTF3A | GTF3AP5 | GTF3C1 | GTF3C2 | GTF3C2-AS1 | GTF3C3 | GTF3C4 | GTF3C5 | GTF3C6 | GTPase | GTPBP1 | GTPBP10 | GTPBP2 | GTPBP3 | GTPBP4